RAPNO DIPG成像标准的手术表现-来自国际DIPG/DMG登记处的研究。

IF 2.5 Q2 CLINICAL NEUROLOGY
Neuro-oncology practice Pub Date : 2025-01-29 eCollection Date: 2025-08-01 DOI:10.1093/nop/npaf015
Hamza S Gorsi, Melike Guryildirim, Michael Kuwabara, Jovan Dhatt, Lindsey M Hoffman, Kenneth J Cohen
{"title":"RAPNO DIPG成像标准的手术表现-来自国际DIPG/DMG登记处的研究。","authors":"Hamza S Gorsi, Melike Guryildirim, Michael Kuwabara, Jovan Dhatt, Lindsey M Hoffman, Kenneth J Cohen","doi":"10.1093/nop/npaf015","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group for diffuse intrinsic pontine glioma (DIPG) recently published its recommendations. We aim to test the operative performance of the RAPNO DIPG criteria imaging component by retrospectively applying it to a patient sample from the International DIPG/DMG Registry (IDIPGR).</p><p><strong>Methods: </strong>Longitudinal MRIs for 46 patients were independently reviewed by 2 pediatric neuro-radiologists. Utilizing RAPNO DIPG imaging criteria for the pontine lesions, response was categorized as complete response (CR), partial response (PR), stable disease (SD), or progressive disease (PD). The response category for each MRI was compared between 2 readers and classified as concordant if they agreed, minor discordant if one reported SD and the other reported PR or PD, and major discordant if one reported PR and the other reported PD.</p><p><strong>Results: </strong>A total of 277 paired MRIs were analyzed, and 124 paired MRIs were evaluated for concordance. The response category was concordant between readers in 84 (68%) MRI comparisons. In 31 MRI comparisons (25%) the reads were minor discordant, and major discordant in 9 (7%). No CRs were reported. Minor discordant cases were within 10% of the boundary for PR or PD in 20 (65%) of these cases. The median difference between the 2 readers' measurements was 2 mm (range 0-29 mm).</p><p><strong>Conclusion: </strong>This study demonstrated that RAPNO DIPG imaging criteria can be applied with concordance or minor discordance between readers in 93% of the cases. Discordant measurements were largely at the boundaries of response type.</p>","PeriodicalId":19234,"journal":{"name":"Neuro-oncology practice","volume":"12 4","pages":"637-643"},"PeriodicalIF":2.5000,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12349774/pdf/","citationCount":"0","resultStr":"{\"title\":\"Operative performance of RAPNO DIPG imaging criteria-a study from the International DIPG/DMG Registry.\",\"authors\":\"Hamza S Gorsi, Melike Guryildirim, Michael Kuwabara, Jovan Dhatt, Lindsey M Hoffman, Kenneth J Cohen\",\"doi\":\"10.1093/nop/npaf015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group for diffuse intrinsic pontine glioma (DIPG) recently published its recommendations. We aim to test the operative performance of the RAPNO DIPG criteria imaging component by retrospectively applying it to a patient sample from the International DIPG/DMG Registry (IDIPGR).</p><p><strong>Methods: </strong>Longitudinal MRIs for 46 patients were independently reviewed by 2 pediatric neuro-radiologists. Utilizing RAPNO DIPG imaging criteria for the pontine lesions, response was categorized as complete response (CR), partial response (PR), stable disease (SD), or progressive disease (PD). The response category for each MRI was compared between 2 readers and classified as concordant if they agreed, minor discordant if one reported SD and the other reported PR or PD, and major discordant if one reported PR and the other reported PD.</p><p><strong>Results: </strong>A total of 277 paired MRIs were analyzed, and 124 paired MRIs were evaluated for concordance. The response category was concordant between readers in 84 (68%) MRI comparisons. In 31 MRI comparisons (25%) the reads were minor discordant, and major discordant in 9 (7%). No CRs were reported. Minor discordant cases were within 10% of the boundary for PR or PD in 20 (65%) of these cases. The median difference between the 2 readers' measurements was 2 mm (range 0-29 mm).</p><p><strong>Conclusion: </strong>This study demonstrated that RAPNO DIPG imaging criteria can be applied with concordance or minor discordance between readers in 93% of the cases. Discordant measurements were largely at the boundaries of response type.</p>\",\"PeriodicalId\":19234,\"journal\":{\"name\":\"Neuro-oncology practice\",\"volume\":\"12 4\",\"pages\":\"637-643\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-01-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12349774/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuro-oncology practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/nop/npaf015\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuro-oncology practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/nop/npaf015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:儿童神经肿瘤学反应评估(RAPNO)工作组最近发表了弥漫性内生性脑桥胶质瘤(DIPG)的建议。我们的目的是通过回顾性地将RAPNO DIPG标准成像组件应用于国际DIPG/DMG登记处(IDIPGR)的患者样本来测试其手术性能。方法:由2名儿科神经放射科医师独立审查46例患者的纵向mri。利用RAPNO DIPG对脑桥病变的成像标准,将反应分为完全缓解(CR)、部分缓解(PR)、病情稳定(SD)或进展性疾病(PD)。比较两名读者对每个MRI的反应类别,如果他们同意,则分为一致,如果一个报告SD,另一个报告PR或PD,则分为轻微不一致,如果一个报告PR而另一个报告PD,则分为严重不一致。结果:共分析了277张配对mri,并对124张配对mri进行了一致性评价。在84个(68%)MRI比较中,读者之间的反应类别是一致的。在31例(25%)MRI比较中,读数轻微不一致,9例(7%)读数严重不一致。无cr报告。其中20例(65%)的轻度不一致病例在PR或PD边界的10%以内。两名阅读者测量值的中位数差为2毫米(范围0-29毫米)。结论:本研究表明,在93%的病例中,读取器之间的一致性或轻微不一致性可以适用RAPNO DIPG成像标准。不一致测量主要在响应类型的边界处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Operative performance of RAPNO DIPG imaging criteria-a study from the International DIPG/DMG Registry.

Background: The Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group for diffuse intrinsic pontine glioma (DIPG) recently published its recommendations. We aim to test the operative performance of the RAPNO DIPG criteria imaging component by retrospectively applying it to a patient sample from the International DIPG/DMG Registry (IDIPGR).

Methods: Longitudinal MRIs for 46 patients were independently reviewed by 2 pediatric neuro-radiologists. Utilizing RAPNO DIPG imaging criteria for the pontine lesions, response was categorized as complete response (CR), partial response (PR), stable disease (SD), or progressive disease (PD). The response category for each MRI was compared between 2 readers and classified as concordant if they agreed, minor discordant if one reported SD and the other reported PR or PD, and major discordant if one reported PR and the other reported PD.

Results: A total of 277 paired MRIs were analyzed, and 124 paired MRIs were evaluated for concordance. The response category was concordant between readers in 84 (68%) MRI comparisons. In 31 MRI comparisons (25%) the reads were minor discordant, and major discordant in 9 (7%). No CRs were reported. Minor discordant cases were within 10% of the boundary for PR or PD in 20 (65%) of these cases. The median difference between the 2 readers' measurements was 2 mm (range 0-29 mm).

Conclusion: This study demonstrated that RAPNO DIPG imaging criteria can be applied with concordance or minor discordance between readers in 93% of the cases. Discordant measurements were largely at the boundaries of response type.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Neuro-oncology practice
Neuro-oncology practice CLINICAL NEUROLOGY-
CiteScore
5.30
自引率
11.10%
发文量
92
期刊介绍: Neuro-Oncology Practice focuses on the clinical aspects of the subspecialty for practicing clinicians and healthcare specialists from a variety of disciplines including physicians, nurses, physical/occupational therapists, neuropsychologists, and palliative care specialists, who have focused their careers on clinical patient care and who want to apply the latest treatment advances to their practice. These include: Applying new trial results to improve standards of patient care Translating scientific advances such as tumor molecular profiling and advanced imaging into clinical treatment decision making and personalized brain tumor therapies Raising awareness of basic, translational and clinical research in areas of symptom management, survivorship, neurocognitive function, end of life issues and caregiving
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信